Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: evidence from cell lines and human tissues
- 7 August 2026
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (4) , 262
Abstract
No abstract availableKeywords
Funding Information
- Manisa Celal Bayar Üniversitesi (2014-169)
This publication has 32 references indexed in Scilit:
- Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospectNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Recent Advances in enhancer of zeste homolog 2 Inhibitors: Structural insights and therapeutic applicationsBioorganic Chemistry, 2024
- Activation of automethylated PRC2 by dimerization on chromatinMolecular Cell, 2024
- EZH2-mediated development of therapeutic resistance in cancerCancer Letters, 2024
- Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinicEBioMedicine, 2024
- EZH2 Expression and Survival for ER+/tamoxifen Treated Breast Cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive BiomarkerArchives of Medical Research, 2023
- The roles of EZH2 in cancer and its inhibitorsMedical Oncology, 2023
- Recurrence and survival in endometrioid endometrial cancer - a population-based cohort studyGynecologic Oncology, 2022
- HOXA10 expression in ectopic endometrial tissueFertility and Sterility, 2006
- Apoptosis May Be an Early Event of Progestin Therapy for Endometrial HyperplasiaGynecologic Oncology, 2000